The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...

Dealing with red, itchy eyelids? The culprit could be a common mite. This article is sponsored by XDEMVY. Dr. Watson is a ...

I turned 50 during the pandemic and, like most people, I put off all nonessential health care, including my shingles vaccine. Big mistake. When the telltale red bumps of shingles cropped up on my ...

Neurotrophic keratitis is historically a rare disease, but now that more understanding has been gained of the underlying etiology and manifestations, its prevalence is starting to increase ...

Leprosy, a chronic and treatable infectious disease, affects the skin, nerves, and mucous membranes. Early detection is ...

2025 is going to be a year of great change. At a macro level, political and geopolitical shifts around the world will reshape ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

The healthcare industry experienced a rollercoaster of a year in 2024, with pharmacy benefits undergoing significant shifts.

The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer.The indication ...

A seemingly harmless nap turned into a life-changing ordeal for a Florida man who lost vision in one eye after sleeping with ...

“RB-PDAT represents a consequential solution for patients at risk of vision loss from severe infectious keratitis,” said Dominic Rodrigues, acting CEO of VisiRose. RB-PDAT treatment has been ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...